Clinical Pathways for pancreatic surgery: Can they improve treatment and outcome quality for patients undergoing pancreatoduodenectomy?

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00017575

Enrollment

298

Registered

2019-07-03

Start date

2015-11-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical pathways in pancreatic surgery

Interventions

Group 1: Patients before CP (Clinical pathways) implementation. Patients were treated regarding the experience and the preference of the surgeon. Group 2: Patients after CP implementation. Patients we

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients undergoing elective pancreatoduodenectomy were included. The intervention group (CP group) comprised all consecutive patients operated following the implementation of the CPs in February 2011. The control group (pre-CP group) comprised all patients operated in the five years before CP implementation.

Exclusion criteria

Exclusion criteria: No exclusion criteria

Design outcomes

Primary

Measure	Time frame
Treatment and outcome quality for patients undergoing distal and total pancreatectomy. Process quality was assessed among others by the following parameters: - day of drain or catheter removal - day of mobilization - day of intake of fluids and solids after surgery Outcome quality was assessed among others by the following parameters: - day of discharge - onset of postoperative diabetes - exocrine pancreas insufficiency	—

Measure

Time frame

Treatment and outcome quality for patients undergoing distal and total pancreatectomy. Process quality was assessed among others by the following parameters: - day of drain or catheter removal - day of mobilization - day of intake of fluids and solids after surgery Outcome quality was assessed among others by the following parameters: - day of discharge - onset of postoperative diabetes - exocrine pancreas insufficiency

—

Secondary

Measure	Time frame
Morbidity (hospital stay and readmission until day 14 after discharge) by assessing postoperative complications (reoperation rate, delayed gastric emptying, bleeding, postoperative pancreatic fistulas, hypoglycemia) according to the Clavien-Dindo classification; mortality (30 days after surgery)	—

Countries

Germany

Contacts

Public ContactUlrich Ronellenfitsch

Klinik für Viszeral-, Gefäß- und Endokrine Chirurgie - Universitätsklinikum Halle (Saale)

ulrich.ronellenfitsch@uk-halle.de0049 345 557 2314

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026